MedTrace Logo

Language Processing and TMS

NCT05425615 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2025-05-11

No results posted yet for this study

Summary

This study will examine the effect of TMS on people with stroke and aphasia as well as healthy individuals.

Conditions

Interventions

DEVICE

Transcranial Magnetic Stimulation

Deymed DuoMag XT-100 rTMS

Sponsors & Collaborators

  • Medical College of Wisconsin

    lead OTHER

Principal Investigators

  • Priyanka Shah-Basak, PhD · Medical College of Wisconsin

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-05
Primary Completion
2032-06-30
Completion
2032-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05425615 on ClinicalTrials.gov